Catalyst Wire Dossier Catalyst Wire Dossier

AN2025

AN2025 · Adlai Nortye Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AN2025, covering 2025-06-22 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors [Phase 1]

See pricing